GSK

@GSK

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: gsk.to/socialmedia

London, UK

GSK
@GSK
Sep 15
#News for #investors and #media: We have entered a licence agreement with Chimagen Biosciences for an investigational T-cell engager for multiple myeloma, advancing our leadership ambitions in blood cancer. Find out more: gsk.com/en-gb/media/pr…
00:00
2
GSK
@GSK
Sep 13
#News for #investors and #media: Today, we announced new positive data at #WCLC26 representing encouraging news for people living with ROS1-positive non-small cell lung cancer. Learn more: gsk.to/4xolucI
00:00
4
GSK
@GSK
Sep 13
#News for #investors and #media: Today, our licensor Hansoh Pharma presented positive data at #WCLC26 from a pivotal trial of an investigational antibody-drug conjugate in our pipeline. Learn more: gsk.to/4xRUa7t
00:00
2
GSK
@GSK
Sep 10
#News for #Investors and #Media: Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a new prefilled syringe presentation of one of our vaccines. Learn more: gsk.to/4xSAW1Q
00:00
1
GSK
@GSK
Sep 9
The data we’ve shared at #ERSCongress underscores how much more we can achieve for respiratory patients when science and partnership come together. Building on our proven track record of innovation, we’re accelerating our R&D programmes in COPD to target multiple inflammatory
00:00